Private finance: Asgard Therapeutics, Vensica Therapeutics, Sigrid Therapeutics, GlycoEra, Home Biosciences, illumigyn, Prilenia Therapeutics

Netherlands: Prilenia Therapeutics, a clinical stage biotech company, raised US$43m in Series B funding, bringing the total capital raised since its founding in September 2018 to US$133.5m. The round was led by Sands Capital with participation from Forbion and Morningside, Amplitude Ventures, Sectoral Asset Management, Talisman and the ALS Investment Fund. The company intends to…